Sorrento Therapeutics

Developer of immuno therapeutics for cancer, inflammation, and autoimmune diseases

placeSan Diego, California, United States calendar_todayFounded 1989 groups949 employees language sorrentotherapeutics.com

Registered entities

Investor mix

11 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital327%
Private equity327%
Bank & private debt19%
Other / undisclosed436%
Coming soon